The patent challenge was about the gun, not what was in it! That is why they lost the case. RenovaCare argued that their gun was unique therefore not impinging on Avita's patent of the ingredients spayed on the skin.
If RenovaCare is using a different solution, where are the trials proving it is safe and effective?
Clinical trial anticipated to commence during the first quarter of 2021.
Has it started yet???
You are muddying the waters with your misinformation.
The patent challenge was about the gun, not what was in it! That...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
-0.070(2.78%) |
Mkt cap ! $163.8M | |||
| Open | High | Low | Value | Volume |
| $2.51 | $2.51 | $2.45 | $415.9K | 167.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 14867 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.48 | 90 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| AVH (ASX) Chart |